These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1553101)

  • 21. 5-HT3 receptors: pharmacologic and therapeutic aspects.
    Gyermek L
    J Clin Pharmacol; 1995 Sep; 35(9):845-55. PubMed ID: 8786244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Withdrawal from continuous cocaine administration: time dependent changes in accumbens 5-HT3 receptor function and behavioral tolerance.
    King GR; Xiong Z; Ellinwood EH
    Psychopharmacology (Berl); 1999 Mar; 142(4):352-9. PubMed ID: 10229059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-HT1 receptors and behavior.
    Lucki I
    Neurosci Biobehav Rev; 1992; 16(1):83-93. PubMed ID: 1553109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The classification of 5-hydroxytryptamine receptors.
    Mylecharane EJ
    Clin Exp Pharmacol Physiol; 1989 Jun; 16(6):517-22. PubMed ID: 2670359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-HT3 receptor over-expression decreases ethanol self administration in transgenic mice.
    Engel SR; Lyons CR; Allan AM
    Psychopharmacology (Berl); 1998 Nov; 140(2):243-8. PubMed ID: 9860116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and structure-activity relationships of 4-amino-5-chloro-N-(1,4-dialkylhexahydro-1,4-diazepin-6-yl)-2-methoxybenzamide derivatives, novel and potent serotonin 5-HT3 and dopamine D2 receptors dual antagonist.
    Hirokawa Y; Harada H; Yoshikawa T; Yoshida N; Kato S
    Chem Pharm Bull (Tokyo); 2002 Jul; 50(7):941-59. PubMed ID: 12130853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Behavioural pharmacology of 5-HT3 receptor antagonists: a critical update on therapeutic potential.
    Greenshaw AJ
    Trends Pharmacol Sci; 1993 Jul; 14(7):265-70. PubMed ID: 8105596
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. 2. Molecular basis of the intrinsic efficacy of arylpiperazine derivatives at the central 5-HT3 receptors.
    Cappelli A; Anzini M; Vomero S; Canullo L; Mennuni L; Makovec F; Doucet E; Hamon M; Menziani MC; De Benedetti PG; Bruni G; Romeo MR; Giorgi G; Donati A
    J Med Chem; 1999 May; 42(9):1556-75. PubMed ID: 10229626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Centrally active 5-HT receptor agonists and antagonists.
    Middlemiss DN; Tricklebank MD
    Neurosci Biobehav Rev; 1992; 16(1):75-82. PubMed ID: 1553108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irritable bowel syndrome: new agents targeting serotonin receptor subtypes.
    De Ponti F; Tonini M
    Drugs; 2001; 61(3):317-32. PubMed ID: 11293643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detailed investigations of 5-HT3 compounds in a drug discrimination model.
    De La Garza R; Callahan PM; Cunningham KA
    Pharmacol Biochem Behav; 1996 Jul; 54(3):533-40. PubMed ID: 8743626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical modulation of 5-HT3 and 5-HT4 receptors affects the release of 5-hydroxytryptamine from the ferret and rat intestine.
    Minami M; Tamakai H; Ogawa T; Endo T; Hamaue N; Hirafuji M; Yoshioka M; Blower PR
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):131-42. PubMed ID: 8556268
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of endogenous dopamine by stimulation of 5-hydroxytryptamine3 receptors in rat striatum.
    Blandina P; Goldfarb J; Craddock-Royal B; Green JP
    J Pharmacol Exp Ther; 1989 Dec; 251(3):803-9. PubMed ID: 2600815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function.
    Palfreyman MG; Schmidt CJ; Sorensen SM; Dudley MW; Kehne JH; Moser P; Gittos MW; Carr AA
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S60-7. PubMed ID: 7831442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The serotonin 5-HT(2A) receptor subtype does not mediate apomorphine-induced aggressive behaviour in male Wistar rats.
    Skrebuhhova-Malmros T; Pruus K; Rudissaar R; Allikmets L; Matto V
    Pharmacol Biochem Behav; 2000 Oct; 67(2):339-43. PubMed ID: 11124399
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of 5-HT3 receptors in basal and K(+)-evoked dopamine release from rat olfactory tubercle and striatal slices.
    Zazpe A; Artaiz I; Del Río J
    Br J Pharmacol; 1994 Nov; 113(3):968-72. PubMed ID: 7858893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacology of VA21B7: an atypical 5-HT3 receptor antagonist with anxiolytic-like properties in animal models.
    Artaiz I; Romero G; Zazpe A; Monge A; Calderó JM; Roca J; Lasheras B; Del Río J
    Psychopharmacology (Berl); 1995 Jan; 117(2):137-48. PubMed ID: 7753959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5-HT3 receptor modulation of behavior during withdrawal from continuous or intermittent cocaine.
    King GR; Joyner CM; Ellinwood EH
    Pharmacol Biochem Behav; 1994 Mar; 47(3):399-407. PubMed ID: 8208757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Possibility of 5-HT3 receptor involvement in alcohol dependence: a microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption.
    Yoshimoto K; Yayama K; Sorimachi Y; Tani J; Ogata M; Nishimura A; Yoshida T; Ueda S; Komura S
    Alcohol Clin Exp Res; 1996 Dec; 20(9 Suppl):311A-319A. PubMed ID: 8986229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.